Capstone Investments Starts Sagent Pharmaceuticals (SGNT) at Buy
Tweet
Share
E-mailGet Alerts SGNT Hot Sheet
Price: $21.76 --0%
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
Capstone Investments initiates coverage on Sagent Pharmaceuticals (NASDAQ: SGNT) with a Buy. PT $27.00.
For an analyst ratings summary and ratings history on Sagent Pharmaceuticals click here. For more ratings news on Sagent Pharmaceuticals click here.
Shares of Sagent Pharmaceuticals closed at $21.50 yesterday.
For an analyst ratings summary and ratings history on Sagent Pharmaceuticals click here. For more ratings news on Sagent Pharmaceuticals click here.
Shares of Sagent Pharmaceuticals closed at $21.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Telenor ASA (TEL:NO) (TELNY) to Neutral
- Citi Starts China Eastern Airlines Corp Ltd. (670:HK) (CEA) at Neutral
- Citi Starts Air China Ltd. (753:HK) (AIRYY) at Sell
Create E-mail Alert Related Categories
New CoverageRelated Entities
Capstone InvestmentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
